Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
28 Juli 2022 - 5:04PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
For the month July 2022
(Commission File No. 001-35193)
Grifols, S.A.
(Translation of registrant’s name into English)
Avinguda de la Generalitat, 152-158
Parc de Negocis Can Sant Joan
Sant Cugat del Valles 08174
Barcelona, Spain
(Address of registrant’s principal executive
office)
Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.
Form 20-F x
Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101 (b) (1):
Yes ¨
No x
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101 (b) (7):
Yes ¨
No x
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
Yes ¨
No x
If “Yes” is marked, indicate below the file number assigned
to the registrant in connection with Rule 12g3-2(b): 82-
Grifols, S.A.
TABLE OF CONTENTS
![GRAPHIC](https://content.edgar-online.com/edgar_conv_img/2022/07/28/0001104659-22-083526_tm2221986d2_6kimg01.jpg)
| Grifols, S.A.
Avinguda de la Generalitat 152-158
08174 Sant Cugat del Vallès
Barcelona - ESPAÑA
Tel. [34] 935 710 500
Fax [34] 935 710 267
www.grifols.com
Pursuant to the provisions of article 227 of the Consolidated Text of the Securities Market Act,
approved by the Legislative Royal Decree 4/2015, of 23 October, Grifols, S.A. ("Grifols")
hereby informs about the following
OTHER RELEVANT INFORMATION
Grifols informs that it has formalised the sale of substantially all of the assets of the business of
its US subsidiary Goetech LLC, whose trade name is MedKeeper ("MedKeeper"), to affiliates
of the US company Becton, Dickinson and Company for a purchase price of approximately US$
93 million.
MedKeeper develops and markets software applications based on web and mobile platforms for
hospital pharmacy and was fully acquired by Grifols in 2020 when it exercised the call option on
the remaining 49% of Medkeeper's share capital, having formalised the purchase of 51% of the
share capital in 2018.
This transaction is part of the divestment plan for non-strategic activities announced by Grifols,
in line with its long-term sustainable growth strategy.
In Barcelona, on 28 July 2022
Ms. Núria Martín Barnés
Secretary to the Board of Directors |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.
|
Grifols, S.A. |
|
|
|
|
By: |
/s/ David I. Bell |
|
|
Name: |
David I. Bell |
|
|
Title: |
Authorized Signatory |
Date: July 28, 2022
Grifols (PK) (USOTC:GIKLY)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Grifols (PK) (USOTC:GIKLY)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Grifols SA (PK) (OTCMarkets): 0 Nachrichtenartikel
Weitere Grifols Sa News-Artikel